– NETHERLANDS, Venlo – QIAGEN N.V. (NYSE: QGEN / FRA QIA) announced the election of Stephen Rusckowski as Chairman of its Supervisory Board following the AGM on June 26, 2025, succeeding Lawrence Rosen, who did not stand for re-election.
Additionally, Prof. Dr. Elaine Mardis stepped down from the Supervisory Board.
About Stephen H. Rusckowski
Stephen Rusckowski joined the Supervisory Board in 2023 and has served as Chairman of the Nomination & Governance Committee and as a member of the Human Resources & Compensation Committee. He brings deep global healthcare and leadership experience, having previously served as Chairman, President, and CEO of Quest Diagnostics and as CEO of Philips Healthcare.
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample-to-Insight solutions, enabling customers to extract and gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. Assay technologies prepare these biomolecules for analysis while bioinformatics software and knowledge bases can be used to interpret data to find actionable insights. Automation solutions bring these processes together into seamless and cost-effective workflows. QIAGEN serves over 500,000 customers globally in Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics) and Molecular Diagnostics for clinical healthcare. As of March 31, 2025, QIAGEN employed more than 5,600 people in over 35 locations worldwide.
For more: https://www.qiagen.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.